Molex has announced plans to open a new 23,000-square-meter facility in Poland, with the aim of significantly expanding its medical device output for Phillips-Medisize.
The new campus aims to employ approximately 350 employees, ranging from production operators to design engineers and quality specialists.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The US-based company and owner of Phillips-Medisize said that the Polish campus will boast technological advances such as advanced medical device assembly, packaging, drug handling and injection moulding.
Set to open in the city of Katowice, the facility marks the 7th facility for the Molex subsidiary in the European Union, joining production sites in Ireland, the Czech Republic, Denmark and Finland, the last of which produces Phillips-Medisize’s needle-free continuous glucose monitor.
Senior vice president for Phillips-Medisize, Paul Chaffin said: “The Katowice campus will expand our European footprint, providing our pharmaceutical, diagnostic and medtech customers with new capabilities and the expert support they need to bring innovative new products to market.
“This ultimately allows us to further our vision of enabling patients all over the world to live healthier, more productive lives. We look forward to becoming an active part of the local community, as we work together to create significant value for our customers, our new team members and ultimately patients.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataIt comes after, Siemens Healthineers, announced plans to cut 300 jobs at its own US-based site, with an aim to merge it with its own Irish manufacturing site.
Chaffin added: “The Katowice campus will expand our European footprint, providing our pharmaceutical, diagnostic and medtech customers with new capabilities and the expert support they need to bring innovative new products to market.”
GlobalData’s Medical Device Intelligence Centre details how Phillips-Medisize currently has five marketed products across the United States and Europe, ranging from drug delivery devices such as the Aria Smart Autoinjector Platform, to healthcare IT systems.
